ArticleCancer investigation2012

Patterns of response in patients with pretreated metastatic melanoma who received ipilimumab 3 mg/kg in a European expanded access program: five illustrative case reports.

Sofie Wilgenhof et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.